2022
DOI: 10.1016/j.bioorg.2022.105683
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of aminothiazole derivatives as novel human enterovirus A71 capsid protein inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 34 publications
0
3
0
Order By: Relevance
“…We next explored whether LL-18 or FF-18 affects viral attachment and internalization. The aminothiazole derivative (12 s ), a small molecule compound reported to inhibit EV71 by interfering with viral VP1-SCARB2 interaction [ 18 ], was used as a positive control. EV71 viruses were pre-incubated with PBS, 12s, LL-18, or FF-18 and then incubated with RD cells at 4°C for 1 hr to allow virus attachment to host cells.…”
Section: Resultsmentioning
confidence: 99%
“…We next explored whether LL-18 or FF-18 affects viral attachment and internalization. The aminothiazole derivative (12 s ), a small molecule compound reported to inhibit EV71 by interfering with viral VP1-SCARB2 interaction [ 18 ], was used as a positive control. EV71 viruses were pre-incubated with PBS, 12s, LL-18, or FF-18 and then incubated with RD cells at 4°C for 1 hr to allow virus attachment to host cells.…”
Section: Resultsmentioning
confidence: 99%
“…Coat proteins are also key antiviral therapeutic targets for many human viruses that infect humans, such as enterovirus A71, enterovirus D68, hepatitis B virus (HBV), and human immunodeficiency virus (HIV). Many compounds have been designed to target viral proteins: 3-(4-Pyridyl)-2-imidazolidinone derivatives (GPP3, EC 50 10 nM), licochalcone A (EC 50 9.30 μM), and aminothiazole derivatives (e.g., 12s , EC 50 0.27 μM) have been designed and synthesized using the enterovirus A71 CP as the target. Pyrazolopyridine analogues (e.g., 7a , EC 50 16.7 μM) are antiviral compounds targeting the enterovirus D68 CP . Heteroaryldihydropyrimidines (e.g., GLS4, EC 50 0.012 mM) are antiviral drugs that target the HBV CP and induce aberrant self-assembly, and GS-6207 (EC 50 105 pM) is an HIV replication inhibitor that targets the HIV-1 CP …”
Section: Introductionmentioning
confidence: 99%
“…CMV CP Inhibitors. DNPE6(11), a homogeneous heteropolysaccharide (EC 50 402.4 ± 2.0 μg/mL) extracted from Dendrobium nobile Lindl., has superior antiviral potency against CMV in comparison with chitosan oligosaccharide and lentinan. 66 DNPE6 (…”
mentioning
confidence: 99%